|Awarded On||January 20, 2010|
|Title||MRI-Guided Laser Therapy for Targeted Treatment of Localized Prostate Cancer|
|Program||Product Development Research|
|Award Mechanism||Company Commercialization|
|Principal Investigator/Program Director||Ashok Gowda|
The primary treatment for prostate cancer has long been radical prostatectomy (surgical removal of the prostate) or whole gland radiation. However, because prostate cancer presents in broadly varying degrees of aggressiveness, recent data show that 42 men who would not otherwise die from the disease must have their prostates removed in order to save one life.
Because the complications of prostatectomy (incontinence, erectile dysfunction) are common and devastating regardless of technique used (manual or robotic surgery), it is clear that prostate cancer is being dramatically over-treated. There is growing evidence that patients with low-risk disease may benefit significantly from a minima...